With a strategic stake in the Bavarian software company up2parts, which specializes in artificial intelligence, DMG MORI plans to acquire important know-how in the field of digitized manufacturing processes. up2parts’ AI-based geometric work piece analysis makes it easy and quick to generate work plans and price calculations for individual work pieces – a digital revolution for the manufacturing industry.
“The AI-supported software solutions by up2parts create the basis for digital manufacturing. 3D construction data can now be captured quickly and runtime calculations are possible in a short time. A huge advantage for our mainly mid-sized customers: processes that have been unorganized until now get unified and professionalized,” says Christian Thönes, Chairman of the Executive Board of DMG MORI AKTIENGESELLSCHAFT.
“DMG MORI will be a partner that gives us access to the international market. In addition, as a start-up we are flexible to develop. We offer complete AI-based and automated value chain processes to manufacturing companies – starting from a batch size of 1,” says Marco Bauer, Managing Director of BAM GmbH, from which up2parts emerges. Already since 2017, 25 software developers are working on AI-solutions for integrated, automated and professional manufacturing processes. The number of employees is planned to double in the short run.
up2parts enhances DMG MORI’s digital solutions portfolio. The focus here is on AI-based optimization and acceleration of procurement and manufacturing processes: from quotation and order entry through work preparation and CAM programming to machine planning. The core of the software solution is artificial intelligence, which analyzes the geometry of each component within seconds on the basis of machine learning algorithms and human know-how. The result is a concrete work plan and the price for manufacturing the component. With each component, the AI “learns”, independently and continuously optimizing its algorithms.
DMG MORI and up2parts have their first joint presentation at the EMO in Hanover. The stake is subject to the approval of the antitrust authorities.
